DUBLIN, May 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) today announced results from two late-breaking clinical trials presented virtually at the 2020 Society for Cardiovascular Angiography and ...

Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio SAN DIEGO — Two-year data from an early ...

For years, innovations in the treatment of pulmonary valve regurgitation have relied on invasive surgical treatments—until now. A device from Medtronic that takes a minimally invasive approach to ...

Researchers have found a way to take a pediatric patient's skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary ...

July 23, 2009 (Gaithersburg, Maryland) — The FDA Circulatory System Devices Panel voted 12 to 0 to recommend approval of a transcatheter pulmonary valve for use under humanitarian device exemption ...

Two new studies presented April 27, 2015, at the American Association for Thoracic Surgery Annual Meeting in Seattle, WA, highlight prognostic markers that may enhance conventional risk assessment of ...

Biventricular correction of tetralogy of Fallot was devised more than 50 years ago. Current short-term outcomes are excellent. The potential for late complications is, however, an important concern ...

Researchers have found a way to take a pediatric patient’s skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary ...

Ten-year outcomes from the Melody Transcatheter Pulmonary Valve (TPV) Therapy demonstrated strong long-term hemodynamic and safety outcomes, while the first-ever results from the investigational ...